BRAINSTORM CELL THERAPEUTICS INC. Current Assets
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Current Assets of $316.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $316.00K.
- 2026-03-31: Assets, Current $184.00K.
- 2025-12-31: Assets, Current $307.00K.
- 2025-09-30: Assets, Current $508.00K.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $316.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $184.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $307.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $508.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.51M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.33M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $385.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $364.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.82M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.26M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.90M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.54M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.21M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.93M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.11M 10-K · filed 2024-04-01 |
| 2022-09-30 | $7.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $12.81M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $19.26M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $23.28M 10-K · filed 2023-03-30 |
| 2021-09-30 | $27.94M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $35.19M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $41.03M 10-Q · filed 2021-04-26 |
| 2020-12-31 | $43.24M 10-K · filed 2022-03-28 |
| 2020-09-30 | $30.34M 10-Q · filed 2020-10-15 |
| 2020-06-30 | $16.63M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $15.21M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.36M 10-K · filed 2021-02-04 |
| 2019-09-30 | $4.67M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.54M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $8.26M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $10.27M 10-K · filed 2020-02-18 |
| 2018-09-30 | $12.62M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $19.56M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $7.87M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $9.62M 10-K · filed 2019-04-01 |
| 2017-09-30 | $10.95M 10-Q · filed 2017-10-17 |
| 2017-06-30 | $7.68M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $8.72M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $10.44M 10-K · filed 2018-03-08 |
| 2016-09-30 | $11.38M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $12.81M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $13.51M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $16.79M 10-K · filed 2017-03-29 |
| 2015-09-30 | $18.09M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $20.06M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $22.08M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $9.58M 10-K · filed 2016-03-09 |
| 2014-09-30 | $11.11M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $12.21M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $3.85M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $4.45M 10-K · filed 2015-03-26 |
| 2013-09-30 | $5.67M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $3.29M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.30M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $4.87M 10-K · filed 2014-03-27 |
| 2012-09-30 | $5.29M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $1.40M 10-Q/A · filed 2012-08-29 |
| 2012-03-31 | $1.77M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $2.30M 10-K · filed 2013-03-14 |
| 2011-09-30 | $2.80M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $3.13M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $579.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |